Taiwan FDA registration a71ba32d3413b3b883ae2ed34c6caae3
"Bard" VIELIACE implantable injection seat
TW: “巴德”威力艾斯植入式注射座
Taiwan·Risk Class 2·BARD ACCESS SYSTEMS, INC.·Registered Mar 12, 2013 – Mar 12, 2028ActiveRegistration details
- Analysis ID
- a71ba32d3413b3b883ae2ed34c6caae3
- Customs Code
- DHA00602478005
Company information
- Manufacturer
- BARD ACCESS SYSTEMS, INC.
- Manufacturer Country
- United States
- Authorized Representative
- BARD PACIFIC HEALTH CARE CO., LTD.
Product details
- Intended Use
- For details, it is Chinese approved copy of the imitation order
- Product Type (Level 1)
- J General hospital and personal use equipment
- Product Type (Level 2)
- J.5965 Subcutaneous implantable intravascular injection port and guide
- Import Information
- import
Dates and status
- Registration Date
- Mar 12, 2013
- Expiry Date
- Mar 12, 2028
About this record
Access comprehensive regulatory information for "Bard" VIELIACE implantable injection seat in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number a71ba32d3413b3b883ae2ed34c6caae3 and manufactured by BARD ACCESS SYSTEMS, INC.. The authorized representative in Taiwan is BARD PACIFIC HEALTH CARE CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices